Fundraising Fox

Satish Jindal

Investor

General Partner at Advent Life Sciences

Cambridge, Massachusetts

Writes $25K – $5M checks Β· typically $1M

About

Satish Jindal joined Advent Life Sciences in January 2022, having previously been CEO of BioMotiv, an operating investment fund. He co-founded and led NeoGenesis (acquired by Schering-Plough), co-founded and served as President of Verastem, and co-founded Elicio Therapeutics, and held Vice President and Site Head roles at Schering-Plough and Bristol-Myers Squibb. He completed postdoctoral research at the Whitehead Institute at MIT and holds a PhD in Biochemistry from Punjab University in India.

Invests in

Biotech

Experience

  1. BioMotiv, Epitopea, Calida, Aleta, Allinaire, Elura, ImmunocodexBoard Membercurrent2022 β€” present
  2. Advent Life SciencesGeneral Partnercurrent2022 β€” presentBoston, MA
  3. ImmunocodexBoard Member and Co-foundercurrent2014 β€” presentCambridge, MA
  4. BioMotivCEO2019 β€” 2021Boston, MA
  5. Elicio TherapeuticsCo-Founder/Founding CEO2010 β€” 2019Greater Boston Area
  6. Allied-Bristol Life SciencesCEO2014 β€” 2019
  7. Bristol-Myers SquibbVice President, BMS;2011 β€” 2014
  8. Verastem, Inc ( VSTM)President/COO; Co-founder2009 β€” 2011
  9. Schering-Plough Research Institute (now Merck)VP and Site Head2005 β€” 2008Cambridge, MA
  10. NeoGenesis Pharmaceuticals (acquired by Schering Plough)CEO, Founder, Chairman, BoD1997 β€” 2005
  11. PerSeptive Biosystems, Inc.Senior Director1995 β€” 1996
  12. Whitehead Institute for Biomedical research, MITPost-doctoral Fellow1988 β€” 1992Cambridge, MA

Education

  1. Massachusetts Institute of TechnologyPost Doctoral Fellow
  2. Department of Biochemistry, PanjabPh.D

Skills & more

FundraisingLife Sciences27Biotechnology29Drug Discovery8Drug Development10Technology Transfer6Clinical Development10Oncology7Biopharmaceuticals7R&D4Biochemistry8Pharmaceutical Industry16

Languages Hindi Β· Russian

From Satish's professional profile.

Same school

Shared employers

Colleagues at Advent Life Sciences